Free App With Your ADHD Prescription: Worth It?

Start a new stimulant prescription and someone hands you a coupon for a wellness app. That’s the pitch as of yesterday. Tris Pharma announced new partnerships with Calm Health and ADHD Central on August 12, 2026, and patients starting DYANAVEL XR now get three months of free access to a clinical mental health app, Calm Health, bundled in with their stimulant.

Free is good. Free from the company selling you the pill is a little more complicated. Let’s get into what’s actually being offered, what’s true and what’s marketing gloss, and whether it’s worth activating.

TL;DR: What’s Actually Happening

Question Answer
Who announced it Tris Pharma, maker of DYANAVEL XR (amphetamine), on August 12, 2026
The app deal 3 months free access to Calm Health, a clinical digital mental health platform, for patients starting DYANAVEL XR
The other “partner” ADHD Central — not an app. A screen-free, paper-based organization system called ON TRACK Cards
Who built Calm Health The makers of Calm, the meditation and sleep app, on a separate clinical-focused platform
What happens after 3 months Not specified in the announcement — Calm’s consumer subscription runs roughly $70/year after any promotional access ends
Our take A real accommodation with a real expiration date. Worth activating. Don’t build anything long-term on it.

Question	Answer
Who announced it	Tris Pharma, maker of DYANAVEL XR (amphetamine), on August 12, 2026
The app deal	3 months free access to Calm Health, a clinical digital mental health platform, for patients starting DYANAVEL XR
The other “partner”	ADHD Central — not an app. A screen-free, paper-based organization system called ON TRACK Cards
Who built Calm Health	The makers of Calm, the meditation and sleep app, on a separate clinical-focused platform
What happens after 3 months	Not specified in the announcement — Calm’s consumer subscription runs roughly $70/year after any promotional access ends
Our take	A real accommodation with a real expiration date. Worth activating. Don’t build anything long-term on it.

What Tris Pharma Actually Announced

DYANAVEL XR is Tris Pharma’s extended-release amphetamine, a Schedule II stimulant approved for ADHD in patients 6 and up, available as both an oral suspension and a tablet. It’s a known name in this category — Tris has spent years positioning itself as the manufacturer that keeps supply steady when other stimulants go through shortage cycles.

The new piece is the bundling. Per the announcement, eligible patients starting DYANAVEL XR get three months of complimentary access to Calm Health, described as a clinical digital mental health platform built by psychologists, offering personalized action plans and evidence-based self-care programs. Tris also introduces patients to ADHD Central, described as a resource for organization and day-to-day support.

Manesh Naidu, Tris Pharma’s Chief Commercial Officer, framed it plainly in the release: “Effective ADHD management often requires more than medication alone.” That’s not a controversial statement — it’s the entire premise of this site. The question is whether the execution backs it up.

It also lands in the middle of an unusually active year for ADHD pharma news. Between Simtriyo’s FDA approval opening up a whole new drug class and now this, manufacturers are competing on more than the molecule. Support infrastructure is becoming part of the pitch.

What Do You Actually Get With the Free App?

Three months of Calm Health access, activated for patients newly starting DYANAVEL XR — a clinical platform with 40+ programs built on CBT, DBT, and ACT frameworks, including ADHD-specific content, not the consumer meditation app most people already associate with the Calm name.
Personalized action plans, generated from an initial assessment, aimed at stress, anxiety, depression, and ADHD-specific challenges rather than generic mindfulness content.
An introduction to ADHD Central’s ON TRACK Cards — a pocket-sized, paper-based daily planning system, not a companion app.
No stated cost after the three months, and no published mechanism for extending or discounting access once the promotional window closes.

That last point is the one worth sitting with before you get excited about “free.”

Wait — ADHD Central Isn’t an App

Here’s the detail that got flattened in most of the coverage of this announcement, including, frankly, the framing of “free app with your prescription” itself: ADHD Central doesn’t make an app.

ADHD Central is a small company founded by Graham Meckling and Claire Butterfield that makes screen-free, paper-based productivity tools. Their flagship product, ON TRACK Cards, is a 3x5 card system — one card per day, with slots for tasks, time blocks, routines, and a doodle box — printed on recycled paper. It’s built on the idea that writing by hand engages working memory in a way that tapping a screen doesn’t.

So of the two “partners” in this announcement, only one of them is actually software. If you came here because the headline said “free app,” the app part of this deal is Calm Health. ADHD Central is the opposite of an app, on purpose, and that’s worth knowing before you go looking for a login that doesn’t exist.

It’s also, honestly, a more interesting partnership than the app one. A stimulant manufacturer explicitly pointing patients toward analog tools instead of another notification-generating app is a small but real acknowledgment that more apps isn’t automatically the answer for ADHD brains — even from a company that profits from the medication side, not the tool side.

Who Actually Built Calm Health

Calm Health isn’t the meditation app you already have on your phone, even though it comes from the same company. It’s a separate clinical platform, built by the team behind Calm, aimed at healthcare partnerships rather than direct-to-consumer downloads. Health plans and now, apparently, pharmaceutical companies sponsor access to it for defined patient populations, which is a different distribution model than “download it from the App Store and hit paywall on day one.”

That distinction matters for what happens when the three months run out. Calm Health itself doesn’t publish standalone consumer pricing — it’s typically accessed through a sponsor, whether that’s an employer health plan or, now, Tris Pharma. The consumer Calm app (the meditation and sleep one) runs around $70 a year or roughly $15 a month once any free tier or promotional period ends. If Calm Health defaults to that same pricing model once a patient’s sponsored window closes, that’s the number to budget for. Nothing in the announcement confirms it will, and nothing rules it out either.

Is This Actually the First Time a Drugmaker Has Done This?

Mostly, but not entirely. Tris Pharma’s framing implies new territory, and bundling an independent, pre-existing consumer wellness brand directly with a specific stimulant is genuinely new as far as we could find. But it’s not the first time an ADHD stimulant maker has shipped an app alongside a prescription.

Noven Pharmaceuticals launched Mindful Patch, a companion app for its XELSTRYM transdermal patch, back in January 2025. The difference is that Mindful Patch is Noven’s own house-built tracking tool — patch reminders, symptom logging, nothing borrowed from an established consumer brand. Calm Health is a name people already recognize, sponsored into a medication relationship rather than built for it. That’s the actual novelty here, and it’s a subtler distinction than “first app ever,” even if it’s the one doing the marketing work.

The Skeptical Read

Free access tied to starting a specific medication is, structurally, a retention tool. Three months is also, not coincidentally, roughly the window where a new prescription either sticks or gets abandoned — the point where side effects have settled, the dose has probably been adjusted once, and a patient is deciding whether this is the med they’re staying on. Handing over a mental health app right at that decision point is good patient support. It’s also good marketing. Both things are true simultaneously, and neither cancels the other out.

None of that makes Calm Health worthless. Digital mental health tools with real clinical grounding tend to outperform the gamified brain-training category that’s flooded this space for years — CBT and ACT-based content has actual evidence behind it, unlike a lot of “train your brain” apps that feel productive without moving any measurable needle. If you’re starting DYANAVEL XR anyway, there’s very little downside to activating three free months of a clinically built platform. The downside shows up in month four, if you’ve built a routine around it and the login stops working.

What To Actually Do With This

If you’re already prescribed DYANAVEL XR or about to start it: activate the Calm Health access. It costs nothing, and even three months of structured, evidence-based content is more than most people get from a stimulant prescription alone. Just don’t hand the app your entire coping toolkit — treat it as a bonus layer, not the foundation.

If you’re deciding whether Calm Health is worth paying for after month three: wait and see what it actually offers you before committing to a subscription. Novelty tends to inflate the “this changed everything” feeling in the first few weeks of any new tool — the same pattern shows up with brain-training apps, where self-reported improvement outpaced what objective testing found. Give it the full window before deciding it’s essential.

If the ADHD Central cards interest you: they’re a separate purchase, not part of the free bundle, so treat that as its own decision rather than something included with the prescription.

Either way, keep your medication logistics on a system that won’t disappear when a promotional period ends. A dedicated pill reminder app is worth having regardless of what wellness extras come bundled with the prescription — free trials expire, but you’ll still need to remember to take the thing every day.

The Bottom Line

Tris Pharma bundling Calm Health with DYANAVEL XR is a real accommodation, not vaporware — a clinically built platform, genuinely useful content, zero cost for three months. It’s also, unavoidably, a marketing hook timed to the exact window when a new prescription is most likely to be abandoned. Both facts sit next to each other without contradiction.

The app half of this deal is worth using. The “app” framing for ADHD Central isn’t accurate at all — that’s paper cards, and a good idea on its own terms. And the real test of this partnership isn’t month one. It’s month four, when the free access ends and you find out whether Calm Health earned a place in your routine or just occupied one for a season.

This reflects information published in Tris Pharma’s August 12, 2026 announcement. Pricing details for continued Calm Health access beyond the promotional period were not published at the time of writing and may change. This is not medical advice — talk to your prescriber before starting or changing any ADHD medication.